Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821184 · ClinicalTrials.gov registry record · Phase 3
Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder
A Phase 3 study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
NCT00821184: Clinical Trial Phase 3 study, sponsored by Lahey Clinic.
NCT00821184 is a Phase 3 study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 12 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00821184, a Phase 3 study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will help determine if behavior modification performed in conjunction with oral Vesicare anticholinergic therapy is more effective for treating overactive bladder symptoms than oral Vesicare anticholinergic therapy alone.
Interventions
- DRUG Vesicare (solifenacin)
- BEHAVIORAL Vesicare (solifenacin) plus behavioral modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Why NCT00821184 stopped before completion
NCT00821184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Vesicare (solifenacin) is the first listed.
NCT00821184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00821184 about?
NCT00821184 is a clinical study titled "Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder". This study will help determine if behavior modification performed in conjunction with oral Vesicare anticholinergic therapy is more effective for treating overactive bladder symptoms than oral Vesicare anticholinergic therapy alone.
What is the current status of trial NCT00821184?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2006-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00821184?
The interventions under investigation include: Vesicare (solifenacin) (DRUG), Vesicare (solifenacin) plus behavioral modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT00821184?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00821184's enrollment target sits among peer trials
12 1984th of 2000 higher than 12 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia